SCHEMBL17870969

SCHEMBL17870969

O=[C]c1ccc(SC(F)(F)F)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
KDM4E B2RXH2 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
PTPRZ1 P23471 4/20 0.46
PTPN1 P18031 2/20 0.45
KIF11 P52732 1/20 0.41
LMNA P02545 5/20 0.37
HTT P42858 2/20 0.37
TRPV1 Q8NER1 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
KCNK2 O95069 2/20 0.36
KCNK10 P57789 2/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
MAPT P10636 2/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
EPHX2 P34913 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6001741 0.81 ALDH1A1 (0.56) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL19638946 0.77 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL695548 0.77 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL516309 0.77 ALDH1A1 (0.52) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL10978325 0.75 ALDH1A1 (0.61) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL513729 0.75 TRPV1 (0.37) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL1745009 0.74 ALDH1A1 (0.44) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL518851 0.73 ALDH1A1 (0.58) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL7527154 0.72 KIF11 (0.49) ALDH1A1KDM4ETDP1PTPRZ1PTPN1
SCHEMBL1020679 0.72 TDP1 (0.47) ALDH1A1KDM4ETDP1PTPRZ1PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230278955-A1 VITAMIN D3 DERIVATIVES AND PHARMACEUTICAL USE THEREOF UNIV KYOTO (JP) 2023-09-07 US disclosed
US-20180265463-A1 Vitamin D3 Derivatives and Pharmaceutical Use Thereof KYOTO UNIVERSITY (JP) 2018-09-20 US disclosed
EP-3237377-A1 VITAMIN D3 DERIVATIVES AND PHARMACEUTICAL USE THEREOF Kyoto University (JP) 2017-11-01 EP disclosed
WO-2016103722-A1 VITAMIN D3 DERIVATIVES AND PHARMACEUTICAL USE THEREOF KYOTO UNIVERSITY (JP) 2016-06-30 WO disclosed
CN-102770479-B Chloro-substituted polyetherimides having improved relative thermal index SABIC INNOVATIVE PLASTICS IP 2014-05-21 CN disclosed
CN-102595891-B Amidoacetonitrile compounds having pesticidal activity NOVARTIS AG 2013-11-13 CN disclosed
CN-102770479-A Chloro-substituted polyetherimides having improved relative thermal index SABIC INNOVATIVE PLASTICS IP 2012-11-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278955-A1 VITAMIN D3 DERIVATIVES AND PHARMACEUTICAL USE THEREOF VDR, CYP24A1, CYP2R1 ALDH1A1 256/4885KDM4E 1757/4885TDP1 4802/4885
US-20180265463-A1 Vitamin D3 Derivatives and Pharmaceutical Use Thereof VDR, CYP24A1, CYP2R1 ALDH1A1 256/4885KDM4E 1757/4885TDP1 4802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.